- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Daclatasvir – March 2015
Daclatasvir; 60mg or 30mg, tablets; Daklinza®
Last updated
3 July 2015